Preclinical pharmacokinetic and pharmacology evaluations of agents being developed for cancer patients.

Ended Awarded Last action

Contract number
HHSN261201600020I
Awardee
Awarding agency
Task orders
1 $2,723 obligated

Award facts

Combined order value
$2,723 Current and potential, with all options
Last date to order 100% complete
IDV ceiling <1% used
$9,900,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task orders

Transactions

Action Obligated Date
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $0

Quick answers

Who was awarded contract HHSN261201600020I?

HHSN261201600020I was awarded to Sri International by National Cancer Institute (National Institutes of Health) on July 1, 2016.

How much is contract HHSN261201600020I worth?

Orders under HHSN261201600020I have obligated $2,723. HHSN261201600020I's own ceiling is $9,900,000.

How many orders have been placed under contract HHSN261201600020I?

1 order has been placed under HHSN261201600020I, the latest on July 1, 2016.

Who can order from contract HHSN261201600020I?

HHSN261201600020I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN261201600020I part of a contract vehicle?

Yes. HHSN261201600020I is part of Pharmacokinetic and Pharmacology Evaluations for Cancer Patients.

Was contract HHSN261201600020I competed?

The extent of competition for HHSN261201600020I was full and open competition. The government received 5 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV